Atlas Trials

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

Clinical trial NCT05973006 · COMPLETED

Trial details

NCT number
NCT05973006
Sponsor
Novavax
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2023-08-16
Primary completion
2024-04-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.